Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
34.1M
-
Shares change
-
-3.61M
-
Total reported value, excl. options
-
$262M
-
Value change
-
-$45.4M
-
Put/Call ratio
-
5.4
-
Number of buys
-
69
-
Number of sells
-
-81
-
Price
-
$7.68
Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q4 2024
181 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q4 2024.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.1M shares
of 38M outstanding shares and own 89.9% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.8M shares), MPM ASSET MANAGEMENT LLC (2.74M shares), BVF INC/IL (2.33M shares), RA CAPITAL MANAGEMENT, L.P. (2.09M shares), JPMORGAN CHASE & CO (2.07M shares), MPM BIOIMPACT LLC (1.75M shares), VANGUARD GROUP INC (1.63M shares), CITADEL ADVISORS LLC (1.43M shares), DIMENSIONAL FUND ADVISORS LP (1.21M shares), and Boxer Capital Management, LLC (947K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.